CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: D-gluconic acid
Accession: CHEBI:33198
browse the term
Definition: A gluconic acid having D-configuration.
Synonyms: related_synonym: (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid; D-Gluconsaeure; D-Glukonsaeure; D-gluco-Hexonic acid; Dextronic acid; Formula=C6H12O7; GLUCONIC ACID; Glycogenic acid; Hexonic acid; InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/t2-,3-,4+,5-/m1/s1; InChIKey=RGHNJXZEOKUKBD-SQOUGZDYSA-N; Maltonic acid; SMILES=OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O
alt_id: CHEBI:20986; CHEBI:4157; CHEBI:42715
xref: CAS:526-95-4; Drug_Central:3264; Gmelin:83545; HMDB:HMDB0000625; KEGG:C00257; KNApSAcK:C00007303
xref_mesh: MESH:C030691
xref: MetaCyc:GLUCONATE; PDBeChem:GCO; PMID:11777404; PMID:17439666; PMID:19577953; PMID:20222845; PMID:21086198; PMID:21424687; PMID:21819772; PMID:22352719; PMID:22541639; PMID:22688246; PMID:22770225; PMID:24024763; Reaxys:1726055; Wikipedia:Gluconic_acid
cyclic_relationship: is_conjugate_acid_of CHEBI:18391; is_enantiomer_of CHEBI:86359
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of ALDH1A2 mRNA
CTD
PMID:16556975
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
App
amyloid beta precursor protein
multiple interactions
ISO
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of gluconic acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of gluconic acid]
CTD
PMID:39172838
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Arnt2
aryl hydrocarbon receptor nuclear translocator 2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of ARNT2 mRNA
CTD
PMID:16556975
NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:138,189,940...138,393,153
G
Atp6v1f
ATPase H+ transporting V1 subunit F
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of ATP6V1F mRNA
CTD
PMID:16556975
NCBI chr 4:58,067,666...58,070,628
G
Casp3
caspase 3
multiple interactions
ISO
gluconic acid promotes the reaction [Zinc Sulfate inhibits the reaction [Aflatoxin B1 results in increased expression of CASP3 mRNA]]
CTD
PMID:27017951
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
multiple interactions
ISO
[gluconic acid co-treated with Zinc Sulfate] inhibits the reaction [Aflatoxin B1 results in increased expression of CASP8 mRNA]
CTD
PMID:27017951
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Cblb
Cbl proto-oncogene B
decreases expression
EXP
gluconic acid results in decreased expression of CBLB mRNA
CTD
PMID:16556975
NCBI chr11:48,589,878...48,756,940
Ensembl chr11:48,592,703...48,756,839
G
Clcn3
chloride voltage-gated channel 3
increases response to substance
ISO
CLCN3 protein results in increased susceptibility to gluconic acid
CTD
PMID:12843258
NCBI chr16:29,127,152...29,200,133
Ensembl chr16:29,127,419...29,200,119
G
Crhr1
corticotropin releasing hormone receptor 1
increases expression
EXP
gluconic acid results in increased expression of CRHR1 mRNA
CTD
PMID:16556975
NCBI chr10:89,040,186...89,083,481
Ensembl chr10:89,040,203...89,083,481
G
Csf1r
colony stimulating factor 1 receptor
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of CSF1R mRNA
CTD
PMID:16556975
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
G
Cyp4a8
cytochrome P450, family 4, subfamily a, polypeptide 8
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of CYP4A8 mRNA
CTD
PMID:16556975
NCBI chr 5:128,702,130...128,733,476
Ensembl chr 5:128,702,131...128,733,476
G
Fyn
FYN proto-oncogene, Src family tyrosine kinase
decreases expression
EXP
gluconic acid results in decreased expression of FYN mRNA
CTD
PMID:16556975
NCBI chr20:42,767,733...42,960,903
Ensembl chr20:42,766,369...42,959,911
G
Gpt
glutamic--pyruvic transaminase
multiple interactions
EXP
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of GPT protein]
CTD
PMID:30031400
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Grk2
G protein-coupled receptor kinase 2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of GRK2 mRNA
CTD
PMID:16556975
NCBI chr 1:201,580,823...201,601,580
Ensembl chr 1:201,581,480...201,601,582
G
Hcn4
hyperpolarization activated cyclic nucleotide-gated potassium channel 4
increases expression
EXP
gluconic acid results in increased expression of HCN4 mRNA
CTD
PMID:16556975
NCBI chr 8:59,222,206...59,259,626
Ensembl chr 8:59,221,653...59,259,639
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
EXP
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of HMGCR mRNA]
CTD
PMID:30031400
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hoxa1
homeobox A1
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of HOXA1 mRNA
CTD
PMID:16556975
NCBI chr 4:81,255,814...81,258,587
Ensembl chr 4:81,255,883...81,258,504
G
Kcnc1
potassium voltage-gated channel subfamily C member 1
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of KCNC1 mRNA
CTD
PMID:16556975
NCBI chr 1:96,902,953...96,944,744
Ensembl chr 1:96,902,953...96,944,744
G
Kif3c
kinesin family member 3C
increases expression
EXP
gluconic acid results in increased expression of KIF3C mRNA
CTD
PMID:16556975
NCBI chr 6:26,367,092...26,406,033
Ensembl chr 6:26,366,531...26,406,130
G
Lcat
lecithin cholesterol acyltransferase
multiple interactions
EXP
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in decreased expression of LCAT mRNA]
CTD
PMID:30031400
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Lpl
lipoprotein lipase
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of LPL mRNA
CTD
PMID:16556975
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Mdh1
malate dehydrogenase 1
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of MDH1 mRNA
CTD
PMID:16556975
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Mdh2
malate dehydrogenase 2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of MDH2 mRNA
CTD
PMID:16556975
NCBI chr12:20,894,269...20,907,225
Ensembl chr12:20,894,262...20,907,271
G
Mt1
metallothionein 1
multiple interactions
ISO
gluconic acid inhibits the reaction [Zinc Sulfate promotes the reaction [Aflatoxin B1 results in increased expression of MT1A mRNA]]
CTD
PMID:27017951
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
multiple interactions
ISO
gluconic acid inhibits the reaction [Zinc Sulfate promotes the reaction [Aflatoxin B1 results in increased expression of MT2A mRNA]]
CTD
PMID:27017951
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of NR1D2 mRNA
CTD
PMID:16556975
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
G
Nr1h3
nuclear receptor subfamily 1, group H, member 3
multiple interactions
EXP
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] affects the reaction [Dietary Fats results in increased expression of NR1H3 mRNA]
CTD
PMID:30031400
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
G
Pak1
p21 (RAC1) activated kinase 1
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PAK1 mRNA
CTD
PMID:16556975
NCBI chr 1:152,111,172...152,226,390
Ensembl chr 1:152,111,188...152,226,383
G
Pgap2
post-GPI attachment to proteins 2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PGAP2 mRNA
CTD
PMID:16556975
NCBI chr 1:156,591,540...156,618,116
Ensembl chr 1:156,591,615...156,618,114
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PRKAR1A mRNA
CTD
PMID:16556975
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
G
Prkca
protein kinase C, alpha
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PRKCA mRNA
CTD
PMID:16556975
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
G
Psen1
presenilin 1
multiple interactions
ISO
[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of gluconic acid; PF-06840003 inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form] results in decreased abundance of gluconic acid]
CTD
PMID:39172838
NCBI chr 6:103,323,052...103,375,088
Ensembl chr 6:103,323,120...103,371,650
G
Ptges
prostaglandin E synthase
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PTGES mRNA
CTD
PMID:16556975
NCBI chr 3:14,177,892...14,189,236
G
Ptpn2
protein tyrosine phosphatase, non-receptor type 2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of PTPN2 mRNA
CTD
PMID:16556975
NCBI chr18:61,229,012...61,294,662
Ensembl chr18:61,229,014...61,294,627
G
Rara
retinoic acid receptor, alpha
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of RARA mRNA
CTD
PMID:16556975
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
G
Rxrg
retinoid X receptor gamma
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of RXRG mRNA
CTD
PMID:16556975
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
G
Sema6c
semaphorin 6C
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of SEMA6C mRNA
CTD
PMID:16556975
NCBI chr 2:182,733,635...182,750,066
Ensembl chr 2:182,737,474...182,746,856
G
Sirpa
signal-regulatory protein alpha
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of SIRPA mRNA
CTD
PMID:16556975
NCBI chr 3:116,819,730...116,858,099
Ensembl chr 3:116,819,726...116,858,098
G
Slc15a2
solute carrier family 15 member 2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of SLC15A2 mRNA
CTD
PMID:16556975
NCBI chr11:64,014,182...64,043,228
Ensembl chr11:64,014,182...64,043,225
G
Slc22a12
solute carrier family 22 member 12
multiple interactions
ISO
gluconic acid promotes the reaction [SLC22A12 protein affects the transport of Uric Acid]
CTD
PMID:14747372
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
G
Slc22a6
solute carrier family 22 member 6
multiple interactions
ISO
gluconic acid inhibits the reaction [SLC22A6 protein affects the transport of Uric Acid]
CTD
PMID:12472777
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a8
solute carrier family 22 member 8
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of SLC22A8 mRNA
CTD
PMID:16556975
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Slc32a1
solute carrier family 32 member 1
decreases expression
EXP
gluconic acid results in decreased expression of SLC32A1 mRNA
CTD
PMID:16556975
NCBI chr 3:147,267,373...147,271,842
Ensembl chr 3:147,267,373...147,271,844
G
Slc6a8
solute carrier family 6 member 8
increases expression
EXP
gluconic acid results in increased expression of SLC6A8 mRNA
CTD
PMID:16556975
NCBI chr X:151,384,675...151,393,979
Ensembl chr X:151,384,675...151,393,979
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
[gluconic acid co-treated with Zinc Sulfate] promotes the reaction [Aflatoxin B1 results in increased expression of SOD1 mRNA]
CTD
PMID:27017951
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
EXP
[[gluconic acid results in increased abundance of Magnesium] co-treated with [Sodium Selenite results in increased abundance of Selenium]] inhibits the reaction [Dietary Fats results in increased expression of SREBF1 mRNA]
CTD
PMID:30031400
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Sstr3
somatostatin receptor 3
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of SSTR3 mRNA
CTD
PMID:16556975
NCBI chr 7:110,092,563...110,109,043
Ensembl chr 7:110,092,575...110,099,769
G
Tas2r106
taste receptor, type 2, member 106
decreases expression
EXP
gluconic acid results in decreased expression of TAS2R10 mRNA
CTD
PMID:16556975
NCBI chr 4:165,313,210...165,314,133
Ensembl chr 4:165,313,210...165,314,133
G
Ube2i
ubiquitin-conjugating enzyme E2I
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of UBE2I mRNA
CTD
PMID:16556975
NCBI chr10:14,277,749...14,294,681
Ensembl chr10:69,701,618...69,702,443 Ensembl chr10:69,701,618...69,702,443
G
Vamp2
vesicle-associated membrane protein 2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of VAMP2 mRNA
CTD
PMID:16556975
NCBI chr10:53,793,581...53,797,815
Ensembl chr10:53,793,923...53,797,809
G
Vax2
ventral anterior homeobox 2
multiple interactions
EXP
[gluconic acid co-treated with Deoxycholic Acid] results in increased expression of VAX2 mRNA
CTD
PMID:16556975
NCBI chr 4:116,195,528...116,219,597
Ensembl chr 4:116,195,528...116,219,594
G
Vps52
VPS52 subunit of GARP complex
increases expression
EXP
gluconic acid results in increased expression of VPS52 mRNA
CTD
PMID:16556975
NCBI chr20:4,920,715...4,931,685
Ensembl chr20:4,860,843...4,931,665
G
Wee1
WEE1 G2 checkpoint kinase
increases expression
EXP
gluconic acid results in increased expression of WEE1 mRNA
CTD
PMID:16556975
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all